GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (MIL:1EW) » Definitions » Debt-to-Asset

Edwards Lifesciences (MIL:1EW) Debt-to-Asset : 0.07 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Edwards Lifesciences Debt-to-Asset?

Edwards Lifesciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €23 Mil. Edwards Lifesciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €620 Mil. Edwards Lifesciences's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was €8,957 Mil. Edwards Lifesciences's debt to asset for the quarter that ended in Mar. 2024 was 0.07.


Edwards Lifesciences Debt-to-Asset Historical Data

The historical data trend for Edwards Lifesciences's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Debt-to-Asset Chart

Edwards Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.10 0.08 0.08 0.07

Edwards Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.08 0.07 0.07 0.07

Competitive Comparison of Edwards Lifesciences's Debt-to-Asset

For the Medical Devices subindustry, Edwards Lifesciences's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Debt-to-Asset falls into.



Edwards Lifesciences Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Edwards Lifesciences's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(22.833 + 614.39) / 8586.054
=0.07

Edwards Lifesciences's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(22.816 + 620.448) / 8957.396
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Edwards Lifesciences  (MIL:1EW) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Edwards Lifesciences Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences (MIL:1EW) Business Description

Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (MIL:1EW) Headlines

No Headlines